Warby Parker (WRBY) Cash & Equivalents (2020 - 2026)
Warby Parker's (WRBY) quarterly Cash & Equivalents came in at $288.2 million in Q1 2026, up 8.74% YoY from $265.1 million in Q1 2025, and up 0.66% on a QoQ basis from $286.4 million in Q4 2025.
Warby Parker (WRBY) Cash & Equivalents (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Cash & Equivalents data on file, last reported at $288.2 million in Q1 2026.
- Quarterly Cash & Equivalents rose 8.74% year-over-year to $288.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $288.2 million (up 8.74% YoY) and the FY2025 annual result came in at $286.4 million, up 12.67% from the prior year.
- Cash & Equivalents advanced to $288.2 million in Q1 2026, from $286.4 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $288.2 million in Q1 2026 to a low of $197.9 million in Q3 2022.
- A 5-year average of $239.3 million and a median of $230.3 million in 2022 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents slipped 25.67% — and 2025, when it grew 20.35%.
- Tracing WRBY's Cash & Equivalents over 5 years: stood at $208.6 million in 2022, then advanced by 3.98% to $216.9 million in 2023, then climbed by 17.18% to $254.2 million in 2024, then climbed by 12.67% to $286.4 million in 2025, then grew by 0.66% to $288.2 million in 2026.
- The last three Cash & Equivalents figures came in at $288.2 million (Q1 2026), $286.4 million (Q4 2025), and $280.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 2.76 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 708.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.33 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | 292.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 292.67 Mn |
| Mar 31, 2026 | 288.25 Mn |
| Dec 31, 2025 | 286.36 Mn |
| Sep 30, 2025 | 280.36 Mn |
| Jun 30, 2025 | 286.38 Mn |
| Mar 31, 2025 | 265.07 Mn |
| Dec 31, 2024 | 254.16 Mn |
| Sep 30, 2024 | 251.03 Mn |
| Jun 30, 2024 | 237.96 Mn |
| Mar 31, 2024 | 220.38 Mn |
| Dec 31, 2023 | 216.89 Mn |
| Sep 30, 2023 | 215.97 Mn |
| Jun 30, 2023 | 212.66 Mn |
| Mar 31, 2023 | 204.26 Mn |
| Dec 31, 2022 | 208.59 Mn |
| Sep 30, 2022 | 197.89 Mn |
| Jun 30, 2022 | 211.60 Mn |
| Mar 31, 2022 | 230.32 Mn |
| Dec 31, 2021 | 256.42 Mn |
| Sep 30, 2021 | 266.24 Mn |